Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc. T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Freeman Capital Management

You all may have seen the big news story on young Jake Freeman making $110MM trading BBBY as part of the meme frenzy.  Turns out his uncle is Dr. Scott Freeman, a former pharmaceutical executive...read more

Seeking Alpha

Seeking Alpha just sent out a notification with THTX's updated investor presentation.  I don't ever remember that happening in the time I've been invested.  It specifically says ...read more

Rockwell Medical Announces Second Quarter 2022 Results

Revenue was $18.7 million for the second quarter 2022, a 16% increase over the first quarter 2022, representing the highest quarterly revenue to-date for Rockwell ...read more

Progress?

2 days in a row with trading volume on THTX over 100,000 shares. Its not much but it is bit better than what had been going on. Hopefully, we get some good cancer news sometime soon and trading volume...read more
@ the Bell: Indexes overcome muted performance
Despite a split among the indices, Canada’s benchmark stock index closed higher on Thursday thanks to a rebound in commodity prices. Gains in energy and materials offset losses in health care.Wall... read article.

RE:RE:RE:RE:PFUDA 10/3 Date

Ah, yes.  I didn't catch that.  Thanks for clarifying.  rate and reply

RE:RE:RE:PFUDA 10/3 Date

just so you are clear, biobob indicated 10/3 was about the pen injector, which is incorrect. It is about the approval of the IV Push form of administration of Trogarzo. The pen injector is being...read more

RE:RE:PFUDA 10/3 Date

Appreciate the education Biobob, qwerty22 and SPCEO1.    rate and reply

RE:PFUDA 10/3 Date

There are traders, not investors, who make it their purpose to invest before such announcements and sell shortly after the announcement of whatever the PDUFA event is. Or sell short before it and...read more

Thematica Insights Report & Investor Guide

Thematica Report: Exploring the opportunities in battery metals

The Market Herald launches Thematica’s latest report: Battery Metals. Understand how battery metals are driving the future. Download today!

Biopsy controlled Phase 2 Nash trial

Nash still gets interest https://seekingalpha.com/news/3874646-89bio-completes-enrollment-in-phase-2-trial-for-nash-treatment  rate and reply

RE:PFUDA 10/3 Date

IV push https://www.theratech.com/news-releases/news-release-details/theratechnologies-presents-results-trogarzor-iv-push "We are pleased to announce that the FDA has accepted our filing and...read more

RE:PFUDA 10/3 Date

Trogarzo pen injector... formality...  rate and reply

PFUDA 10/3 Date

Someone on Yahoo Finance and Stocktwits posted something about a 10/3 date.  This is not something I have any knowledge on, but after some quick research, there are investors that follow these...read more
Buzz on the Bullboards: Debates among the top sectors
If you’re looking to see the stocks that investors have been keeping an eye on over the past week, you’ve come to the right place. The Bullboard community regularly acts as a microcosm of investor... read article.

RE:RE:Low closing

It's becoming a bit stupid to sell at these levels.. I mean if sales stay the way they are and that they stop spending because th1902 fails you become cash flow positive... markets are just stupid...read more

RE:Low closing

It was a good day.. just someone that made the close look bad  rate and reply

Low closing

Looks like it's done on purpose... have fun until they put out 1902 works...  rate and reply

RE:RE:RE:RE:RE:RE:RE:RE:Nasdaq

Sad to see today's price action on better volume.  rate and reply
@ the Bell: Markets struggle to find ground
Mounting losses throughout the day weighed on Canada’s main stock index on Wednesday. The tech sector led losses, followed by mining, telecom, health care, and financials.Sponsored byU.S. stock-in... read article.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:410 shares

Right - around 230,000 of the warrants have already been exercised and brought in US$750,000.  There remains 8,130,550 as of quarter end and they'll exercise at US$3.18 until Jan 2024.  ...read more

RE:RE:RE:RE:RE:RE:RE:Nasdaq

The good news is that there is someone buying ...  rate and reply

RE:RE:RE:RE:RE:RE:Nasdaq

Looks like someone is selling   rate and reply

RE:RE:RE:RE:RE:Nasdaq

What a yoyo....  rate and reply

RE:RE:RE:RE:Nasdaq

The difference between the exercise price if the option  and the market price on the date of the exercise is a capital gain 50% of which is added to your iincome Exerciding  a warrant to...read more